C12N2760/18411 - CPC Classification Index

ClassID:

110955 ⎘

C12N2760/18411 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae Morbillivirus, e.g. Measles virus, canine distemper

Sub-classes:

C12N2760/18421 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 36
C12N2760/18422 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 97
C12N2760/18423 » Virus like particles [VLP] 8
C12N2760/18431 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2760/18432 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 28
C12N2760/18433 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 18
C12N2760/18434 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 150
C12N2760/18441 » Use of virus, viral particle or viral elements as a vector 8
C12N2760/18451 » Methods of production or purification of viral material 25
C12N2760/18461 » Methods of inactivation or attenuation 3
C12N2760/18471 » Demonstrated in vivo effect 17
C12N2760/18488 » For redistribution 0

Recent Application in this class:

20200108136

Methods and compositions for live attenuated viruses

20170100474

Methods and compositions for live attenuated viruses

20150126564

Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand RNA virus infections

20110064723

Formulation for room temperature stabilization of a live attenuated bacterial vaccine

20080248551

Methods and compositions for live attenuated viruses

20080241881

Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells